selected scholarly activity
-
conferences
- Pulmonary artery catheterization in patients with cardiogenic shock: a systematic review and meta-analysis. Canadian Journal of Anaesthesia. 1611-1629. 2021
- Over & Underground Spaces & Networks Integrations a Case Study: The International District of Montreal. Procedia Engineering. 726-729. 2016
- Inflammation Markers and The Risk Of Post Thrombotic Syndrome: Results From The Bio-Sox Study. Blood. 36-36. 2013
- Predictors Of The Post-Thrombotic Syndrome In a Large Cohort Of Patients With Proximal DVT: Secondary Analysis Of The Sox Trial. Blood. 460-460. 2013
- The Effectiveness Of 30-40 Mm Hg Compression Stockings To Treat Acute Leg Pain Associated With Proximal Deep Vein Thrombosis: Results From The Sox Randomized Controlled Trial. Blood. 1126-1126. 2013
- Decision-Making About Goals of Care for Hospitalized Patients With Heart Failure (Decide-HF): A Pilot Study. Canadian Journal of Cardiology. S139-S140. 2013
- Altered Executive Function in Older Heart Failure Patients at Hospital Discharge: New Data from the Montreal Cognitive Assessment Tool. Journal of Cardiac Failure. S83-S84. 2013
- Prevalence, risk factors, treatment and outcomes of catheter-related thrombosis in patients with malignancies.. Journal of Clinical Oncology. 2013
- High Prevalence of Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge. Circulation. 2012
- A Multicenter Randomized Placebo Controlled Trial of Compression Stockings to Prevent the Post-Thrombotic Syndrome After Proximal Deep Venous Thrombosis: The S.O.X. Trial. Blood. 393-393. 2012
- A Multicenter Randomized Placebo Controlled Trial of Compression Stockings to Prevent the Post-Thrombotic Syndrome After Proximal Deep Venous Thrombosis: The SOX Trial. Blood. 2012
- 652 Use of Computers and Other Technologies By Older Heart Failure Patients and Their Caregivers. Canadian Journal of Cardiology. S345-S345. 2012
- 656 The Association Between Cognitive Function and Self-Care in Older Patients With Heart Failure. Canadian Journal of Cardiology. S347-S347. 2012
- 822 Cognitive Impairment in Older Heart Failure Patients at Hospital Discharge and its Impact on Self-Care - Results of a Prospective Study. Canadian Journal of Cardiology. S415-S416. 2012
- N008 New Insight Into Predictors of Self-Care Confidence in Older Patients With Heart Failure. Canadian Journal of Cardiology. S422-S422. 2012
- DEPRESSION AND NEUROHORMONAL MODULATION IN PATIENTS UNDERGOING TREATMENT FOR CONGESTIVE HEART FAILURE: RANDOMIZED EVALUATION OF STRATEGIES FOR LEFT VENTRICULAR DYSFUNCTION SUBSTUDY. Journal of the American College of Cardiology. E899-E899. 2012
- The Prevalence of Anti-Factor VIII Antibodies in the Hemophilia A Population of the Quebec Province of Canada: Results of Testing with the Bethesda/Nijmegen Assay and with Three ELISA Assays.. Blood. 535-535. 2009
- Quality of Life Questionnaire Responsiveness and Lack of Relationship to Functional Capacity: Findings From the Exercise Rehabilitation Trial (EXERT). Circulation. S511-S511. 2009
- Prescribing Barriers to Heart Failure Management in Primary Care. Circulation. S1028-S1028. 2008
- Managing palliative care for patients with advanced heart failure. Journal of Palliative Care. 196-196. 2008
- Congestive heart failure assessment and management in primary care (CHAMP-C). Canadian Journal of Cardiology. 298C-298C. 2007
- 344 Managing uncertainty in heart failure: preferences of physicians and patients regarding prognosis communication. European Journal of Heart Failure, Supplement. 78-79. 2007
- Carboxyl-terminal fragments of PTH inhibit rPTH(1-34) induced 1,25(OH)(2) vitamin D synthesis and renal CYP28B1 mRNA expression in parathyroidectornized rats.. Journal of Bone and Mineral Research. S442-S442. 2006
- Importance of the calcium/phosphorus ratio in the growth plate normalisation during vitamin D and calcium repletion in the rat.. Journal of Bone and Mineral Research. S335-S335. 2006
- Effect of recombinant human growth hormone on functional capacity and quality of life in heart failure patients: Results from the growth hormone in heart failure trial (GIFT). Circulation. U565-U565. 2005
- Impact of candesartan in preventing myocardial infarction: Results of the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) programme. Circulation. 514-514. 2004
- Unrecognized cognitive impairment is common in heart failure outpatients. Circulation. 640-640. 2004
- Benefits of Exercise in Patients with Congestive Heart Failure. FRONTIERS IN CARDIOVASCULAR HEALTH. 507-517. 2003
- Calcitriol regulates the expression of genes encoding all three vitamin D3-hydroxylases in the human fetal intestine.. Journal of Bone and Mineral Research. S292-S292. 2002
- Angiotensin receptor blockers in heart failure: Meta-analysis of randomized controlled trials. Circulation. 596-596. 2001
- Substantial between hospital variation in outcome following first emergency admission for heart failure. European Heart Journal. 258-258. 2001
- An integrated approach to the design of double facades in canadian non-domestic buildings: A case study. PROCEEDINGS OF THE 4TH INTERNATIONAL CONFERENCE ON INDOOR AIR QUALITY, VENTILATION AND ENERGY CONSERVATION IN BUILDINGS, VOLS I-III. 937-944. 2001
- Influence of the calcium and vitamin D status on Ca2+ signaling, the state of the IP3-sensitive Ca2+ pools, and endoplasmic reticulum calcium binding proteins.. Journal of Bone and Mineral Research. S219-S219. 1999
- Cost effectiveness of the platelet function analyzer (PFA)-100 as a screening test of platelet related primary haemostasis. Thrombosis and Haemostasis. 803-803. 1999
- Use of recombinant factor VIIa (rFVIIa) for bleeding and surgery in patients with Glanzmann thrombasthenia. Thrombosis and Haemostasis. 745-745. 1999
- Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial. American Journal of Cardiology. 19L-24L. 1998
- The steady state expression of the gene encoding the hepatic mitochondrial vitamin D-3 25-hydroxylase (CYP27) is not regulated by the vitamin D or calcium status.. Journal of Bone and Mineral Research. S393-S393. 1997
- Blind comparison of enoxaparin (a low molecular weight heparin) with standard heparin in the treatment of unstable coronary artery disease ''the ESSENCE trial''. Thrombosis and Haemostasis. S1528-S1528. 1997
- Correlation between protein C levels and DNA testing in a large cohort of protein C deficient individuals. Thrombosis and Haemostasis. P1708-P1708. 1997
- Factor V Leiden: A reliable screening assay based on activated partial thromboplastin time (APTT). Thrombosis and Haemostasis. PS83-PS83. 1997
- The incidence of venographically proven deep-vein thrombosis in patients undergoing knee arthroscopy. Thrombosis and Haemostasis. O2397-O2397. 1997
- Hemorrhage incidence with low molecular weight heparin vs unfractionated heparin in patients with unstable angina or non-Q-wave myocardial infarction. Journal of the American College of Cardiology. 3335-3335. 1997
- Redescription of representations: How many levels can be proposed. International Journal of Psychology. 4464-4464. 1996
- A COMPARATIVE-STUDY OF HEMATOLOGIC AND COAGULATION ABNORMALITIES INDUCED BY ANABOLIC-STEROIDS IN WEIGHT LIFTERS. Thrombosis and Haemostasis. 958-958. 1995
- NO CARRYOVER ARTIFACT WHEN USING THE RECOMBINANT THROMBOPLASTIN INNOVIN ON THE AUTOMATED BEHRING FIBRINTIMER-A (BFA). Thrombosis and Haemostasis. 1248-1248. 1995
- PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL, COMPARING A LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENT (ENOXAPARIN) TO WARFARIN. Thrombosis and Haemostasis. 1103-1103. 1995
- RESISTANCE TO ACTIVATED PROTEIN-C (APC-R) IN THROMBOPHILIC PATIENTS - SUMMARY OF RESULTS AFTER 7 MONTHS OF INVESTIGATION. Thrombosis and Haemostasis. 1370-1370. 1995
- D-DIMER IN PATIENTS WITH CLINICALLY SUSPECTED PULMONARY-EMBOLISM (PE). Thrombosis and Haemostasis. 1356-1356. 1993
- INCREASED THROMBIN GENERATION AND ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) AND ANTICARDIOLIPIN ANTIBODIES (ACA) - EVIDENCE FOR A PROTHROMBOTIC STATE. Thrombosis and Haemostasis. 954-954. 1993
- INR - EVALUATION OF A RECOMBINANT HUMAN TISSUE FACTOR FOR PROTHROMBIN TIME (PT) AND COMPARISON WITH A HUMAN PLACENTA THROMBOPLASTIN EXTRACT. Thrombosis and Haemostasis. 663-663. 1993
- LOW FREE PROTEIN-6 LEVELS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS. Thrombosis and Haemostasis. 1227-1227. 1993
- PROTHROMBIN TIME (PT) - COMPARISON OF 2 RECOMBINANT HUMAN TISSUE FACTOR PREPARATIONS WITH A HUMAN PLACENTA THROMBOPLASTIN EXTRACT. Thrombosis and Haemostasis. 663-663. 1993
- CHRONIC HYPOCALCEMIA OF VITAMIN-D DEPLETION PERTURBS HEPATIC INTRACELLULAR CALCIUM-CONCENTRATION, AND EGF RECEPTOR DENSITY AND RESPONSE. Journal of Bone and Mineral Research. S160-S160. 1992
- LESSONS FROM 17 YEARS OF ENVIRONMENTAL MONITORING AT THE LA GRANDE PROJECT, QUEBEC, CANADA. HYDROPOWER 92. 273-280. 1992
- REPERCUSSIONS OF HYDROELECTRIC DEVELOPMENTS IN NORTHERN QUEBEC, CANADA - THE CASE OF THE LA GRANDE COMPLEX IN JAMES BAY. HYDROPOWER 92. 253-259. 1992
- COMPRESSION ULTRASONOGRAPHY (CU) AND IMPEDANCE PLETHYSMOGRAPHY (IPG) FOR THE DETECTION OF VENOUS THROMBOSIS (VT) IN PATIENTS (PTS) WHO HAVE UNDERGONE MAJOR HIP OR KNEE SURGERY. Thrombosis and Haemostasis. 1173-1173. 1991
- TEFLON CATHETER USE FOR SUBCUTANEOUS HEPARIN ADMINISTRATION DURING PREGNANCY - A RANDOMIZED CROSSOVER STUDY. Thrombosis and Haemostasis. 924-924. 1991
- THROMBIN-ANTITHROMBIN III COMPLEXES (TAT) IN PULMONARY-EMBOLISM (PE). Thrombosis and Haemostasis. 980-980. 1991
-
journal articles
- Factors Impacting Physician Prognostic Accuracy in Heart Failure Patients With Reduced Left Ventricular Ejection Fraction. JACC: Heart Failure. 12:878-889. 2024
- Association of a Heart Failure Management Incentive in Primary Care With Clinical Outcomes: A Retrospective Cohort Study. Journal of the American Heart Association. 13:e031498. 2024
-
Obesity in heart failure with preserved ejection fraction: Insights from the
REDUCE LAP‐HF II trial. European Journal of Heart Failure. 26:177-189. 2024 - Epidemiology and treatment of heart failure with chronic obstructive pulmonary disease in Canadian primary care. ESC heart failure. 10:3612-3621. 2023
- The “Weekend Effect” in Patients Admitted With Heart Failure: An Important Gap in Care?. Journal of Cardiac Failure. 29:1367-1368. 2023
- Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure. 11:1103-1117. 2023
- Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study. Circulation. Heart Failure. 16:e010312. 2023
- Letter by Wong and Demers Regarding Article, “Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial”. Circulation. 147:1118-1118. 2023
- Cardiovascular outcomes in children with Kawasaki disease: a population-based cohort study. Pediatric Research. 93:1267-1275. 2023
- The predictive utility of functional status at discharge: a population-level cohort analysis. BMC Geriatrics. 22:8. 2022
- The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies. CJC OPEN. 4:667-675. 2022
- High-Dose Thiamine Supplementation in Older Patients With Heart Failure: A Pilot Randomized Controlled Crossover Trial (THIAMINE-HF). CJC OPEN. 4:532-539. 2022
- A regional Canadian expert consensus on recommendations for restoring exercise and pulmonary function testing in low and moderate-to-high community prevalence coronavirus disease 2019 (COVID-19) settings. Infection Control and Hospital Epidemiology. 42:1535-1537. 2021
- Strategies to Reduce Out-of-Pocket Medication Costs for Canadians Living with Heart Failure. Cardiovascular Drugs and Therapy. 35:1009-1023. 2021
- Incidence and short-term outcomes of Kawasaki disease. Pediatric Research. 90:670-677. 2021
- Uptake of the Heart Failure Management Incentive Billing Code by Family Physicians in Ontario, Canada: A Retrospective Cohort Study. Canadian Journal of Cardiology. 37:508-512. 2021
- Correction: Using an Electronic App to Promote Home-Based Self-Care in Older Patients With Heart Failure: Qualitative Study on Patient and Informal Caregiver Challenges. JMIR Cardio. 4:e25624-e25624. 2020
- Using an Electronic App to Promote Home-Based Self-Care in Older Patients With Heart Failure: Qualitative Study on Patient and Informal Caregiver Challenges. JMIR Cardio. 4:e15885-e15885. 2020
- Evaluation of Heart Failure Apps to Promote Self-Care: Systematic App Search. JMIR mHealth and uHealth. 7:e13173-e13173. 2019
- Predictors of 1-year compliance with adaptive servoventilation in patients with heart failure and sleep disordered breathing: preliminary data from the ADVENT-HF trial. European Respiratory Journal. 53:1801626-1801626. 2019
- Thiamine versus placebo in older heart failure patients: study protocol for a randomized controlled crossover feasibility trial (THIAMINE-HF). Pilot and Feasibility Studies. 4:149. 2018
- Patterns of Care During the Terminal Hospital Admission for Patients With Advanced Heart Failure: A Retrospective Cohort Study. Canadian Journal of Cardiology. 34:1215-1218. 2018
- Canadian Guidelines Need Synchronized Efforts With Rigorous and Transparent Methodology. Canadian Journal of Cardiology. 34:813.e1-813.e1. 2018
- Barriers to Goals of Care Discussions With Patients Who Have Advanced Heart Failure: Results of a Multicenter Survey of Hospital-Based Cardiology Clinicians. Journal of Cardiac Failure. 23:786-793. 2017
- Multidisciplinary Heart Failure Clinics Are Associated With Lower Heart Failure Hospitalization and Mortality: Systematic Review and Meta-analysis. Canadian Journal of Cardiology. 33:1237-1244. 2017
- Barriers to technology use among older heart failure individuals in managing their symptoms after hospital discharge. International Journal of Medical Informatics. 105:136-142. 2017
- La version franco-canadienne de l'outil Assessment of Multiple Systematic Reviews (AMSTAR). Physiotherapy Canada. Physiotherapie Canada. 69:20-29. 2017
- Barriers to goals of care discussions with hospitalized patients with advanced heart failure: feasibility and performance of a novel questionnaire. ESC heart failure. 3:245-252. 2016
- Une version franco-canadienne de la Physiotherapy Evidence Database (PEDro) Scale : L'Échelle PEDro. Physiotherapy Canada. Physiotherapie Canada. 67:232-239. 2015
- Care in the Home for the Management of Chronic Heart Failure. Journal of Cardiovascular Nursing. 30:S44-S51. 2015
- Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study. Open Cardiovascular Medicine Journal. 8:94-101. 2014
- Cognitive function and self-care management in older patients with heart failure. European Journal of Cardiovascular Nursing. 13:277-284. 2014
- Graduated compression stockings to treat acute leg pain associated with proximal DVT. Thrombosis and Haemostasis. 112:1137-1141. 2014
- Living and dying with heart failure in long-term care: experiences of residents and their family members. International Journal of Palliative Nursing. 19:375-382. 2013
- The Ace of Spades: Reverse Takotsubo Cardiomyopathy in the Context of Angiographic Embolization of Recurrent Metastatic Serotonin-Positive Neuroendocrine Tumour of the Pancreas. Case Reports in Medicine. 2013:1-4. 2013
- Does gynecologic malignancy predict likelihood of a tertiary palliative care unit hospital admission? A comparison of local, provincial and national death rates. Palliative and Supportive Care. 10:249-254. 2012
- Shared Electronic Vascular Risk Decision Support in Primary Care. JAMA Internal Medicine. 171:1736-1736. 2011
- Managing palliative care for adults with advanced heart failure.. Canadian Journal of Nursing Research. 43:38-57. 2011
- Screening for Cognitive Deficits Using the Montreal Cognitive Assessment Tool in Outpatients ≥65 Years of Age With Heart Failure. American Journal of Cardiology. 107:1203-1207. 2011
- Reduced Hepatic Synthesis of Calcidiol in Uremia. Journal of the American Society of Nephrology. 21:1488-1497. 2010
- Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. Journal of Thrombosis and Haemostasis. 7:58-64. 2009
- Heart failure: Old disease, older adults, fresh perspective. Geriatrics and Aging. 11:15-21. 2008
- Preferences of patients with heart failure for prognosis communication. Canadian Journal of Cardiology. 23:791-796. 2007
- Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z. Journal of Thrombosis and Haemostasis. 5:1325-1327. 2007
- Heart failure and cognitive impairment: challenges and opportunities.. Clinical interventions in aging. 2:209-218. 2007
- Plasma Matrix Metalloproteinase-9 Level Is Correlated With Left Ventricular Volumes and Ejection Fraction in Patients With Heart Failure. Journal of Cardiac Failure. 12:514-519. 2006
- Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study. Journal of Thrombosis and Haemostasis. 4:1228-1236. 2006
- Corrigendum to “Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis” [Eur J Heart Fail 7 (2005) 1133—1144]. European Journal of Heart Failure. 8:223-224. 2006
- Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Canadian Journal of Cardiology. 22:23-45. 2006
- Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis. European Journal of Heart Failure. 7:1133-1144. 2005
- Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure. Journal of the American Medical Association (JAMA). 294:1794-1794. 2005
- Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?. Expert Opinion on Investigational Drugs. 14:1009-1018. 2005
- Can activated recombinant factor VII be used to postpone the exposure of infants to factor VIII until after 2 years of age?. Haemophilia. 11:335-339. 2005
- Chronic venous abnormalities in symptomatic and asymptomatic protein C deficiency. Journal of Thrombosis and Haemostasis. 3:1428-1431. 2005
- Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis. Journal of Thrombosis and Haemostasis. 3:718-723. 2005
- ACE Inhibitors in Heart Failure. American Journal of Cardiovascular Drugs. 5:351-359. 2005
- Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes. Canadian Journal of Physiology and Pharmacology. 83:98-103. 2005
- Valsartan plus captopril did not improve survival more than captopril alone after myocardial infarction. ACP journal club. 141:3-3. 2004
- Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. Journal of Thrombosis and Haemostasis. 2:743-749. 2004
- Rapid increase in statins newly dispensed to Ontario seniors between 1994 and 2000.. Canadian Journal of Cardiology. 19:665-669. 2003
- Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug‐metabolizing enzyme CYP3A4 in the human fetal intestine. Clinical Endocrinology. 58:489-499. 2003
- The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.. Canadian Journal of Cardiology. 19:347-356. 2003
- Growth Hormone Therapy in Heart Failure: Where Are We Now?. Congestive Heart Failure. 9:84-90. 2003
- The Role of Angiotensin II Receptor Blockers in the Treatment of Heart Failure Patients. Congestive Heart Failure. 9:29-34. 2003
- Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. American Heart Journal. 144:597-607. 2002
- Review: angiotensin receptor blockers do not reduce mortality or hospital admission rates in heart failure. BMJ Evidence-Based Medicine. 7:141-141. 2002
- Substantial between-hospital variation in outcome following first emergency admission for heart failure. European Heart Journal. 23:650-657. 2002
- Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials. Journal of the American College of Cardiology. 39:463-470. 2002
- The endocarditis that was not: an unusual case of heparin-induced thrombocytopenia with unusual complications.. Canadian Journal of Cardiology. 17:1180-1182. 2001
- Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. American Heart Journal. 142:698-703. 2001
- Cost-effectiveness of β-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada. American Heart Journal. 142:537-543. 2001
- Atrial myxoma presenting as isolated unilateral blindness: a case report and review of the literature.. Canadian Journal of Cardiology. 17:898-900. 2001
- Angiotensin receptor blockers for heart failure. Cochrane Database of Systematic Reviews. CD003040. 2001
- Evidence of a Founder Effect for the Protein C Gene 3363 Inserted C Mutation in Thrombophilic Pedigrees of French Origin. Thrombosis and Haemostasis. 86:1000-1006. 2001
- Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease - One-year results of the ESSENCE study. Journal of the American College of Cardiology. 36:693-698. 2000
- Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.. Journal of the American College of Cardiology. 36:693-698. 2000
- Influence of the in Vivo Calcium Status on Cellular Calcium Homeostasis and the Level of the Calcium-Binding Protein Calreticulin in Rat Hepatocytes. Molecular Endocrinology. 141:891-900. 2000
- Influence of the in Vivo Calcium Status on Cellular Calcium Homeostasis and the Level of the Calcium-Binding Protein Calreticulin in Rat Hepatocytes*. Endocrinology. 141:891-900. 2000
- Exercise training for patients with chronic heart failure reduced mortality and cardiac events and improved quality of life. Western Journal of Medicine. 172:28-28. 2000
- The role of digitalis in the treatment of heart failure. Coronary Artery Disease. 10:353-360. 1999
- Hypercalcemic cardiomyopathy associated with primary hyperparathyroidism mimicking primary obstructive hypertrophic cardiomyopathy.. Canadian Journal of Cardiology. 14:1397-1400. 1998
- Type I protein C deficiency in French Canadians: evidence of a founder effect and association of specific protein C gene mutations with plasma protein C levels.. Thrombosis and Haemostasis. 80:551-556. 1998
- Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.. American Journal of Cardiology. 82:19L-24L. 1998
- ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events.. Canadian Journal of Cardiology. 14 Suppl E:15E-19E. 1998
- Comparative in vivo expression of the calcitriol-24-hydroxylase gene in kidney and intestine. Journal of Molecular Endocrinology. 18:37-48. 1997
- Oral calcium transiently increases calbindin9k gene expression in adult rat duodena. Calcified Tissue International. 60:43-47. 1997
- The Essence Trial: Efficacy and Safety of Subcutaneous Enoxaparin in Unstable Angina and Non-Q-Wave MI: A Double-Blind, Randomized, Parallel-Group, Multicenter Study Comparing Enoxaparin and Intravenous Unfractionated Heparin: Methods and Design.. Journal of Thrombosis and Thrombolysis. 4:271-274. 1997
- Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: Response to calcium, vitamin D3 and calcitriol administration in vivo. Journal of Bone and Mineral Research. 10:1148-1157. 1995
- Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 153:19-25. 1995
- The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentrates. Transfusion. 35:548-551. 1995
- The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study. JAMA Internal Medicine. 153:841-844. 1993
- Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Canadian Hemophilia Clinic Directors Group.. The BMJ. 306:306-307. 1993
- An Antithrombin III Assay Based on Factor Xa Inhibition Provides a More Reliable Test to Identify Congenital Antithrombin III Deficiency Than an Assay Based on Thrombin Inhibition. Thrombosis and Haemostasis. 69:231-235. 1993
- D-Dimer and Thrombin-Antithrombin III Complexes in Patients with Clinically Suspected Pulmonary Embolism. Thrombosis and Haemostasis. 67:408-412. 1992
- Measurement of Markers of Activated Coagulation in Antithrombin III Deficient Subjects. Thrombosis and Haemostasis. 67:542-544. 1992
- Ventilation-Perfusion Lung Scanning and the Diagnosis of Pulmonary Embolism: Improvement of Observer Agreement by the Use of a Lung Segment Reference Chart. Thrombosis and Haemostasis. 68:245-249. 1992
- Mercury evolution (1978–1988) in fishes of the La Grande hydroelectric complex, Quebec, Canada. Water, Air, and Soil Pollution. 56:405-417. 1991